Publishing research using ab5386? Please let us know so that we can cite the reference in this datasheet.

ab5386 has been referenced in 7 publications.

  • Kim HS  et al. Morphological characteristics of vasculogenic mimicry and its correlation with EphA2 expression in gastric adenocarcinoma. Sci Rep 9:3414 (2019). PubMed: 30833656
  • Zeng L  et al. A Novel EphA2 Inhibitor Exerts Beneficial Effects in PI-IBS in Vivo and in Vitro Models via Nrf2 and NF-?B Signaling Pathways. Front Pharmacol 9:272 (2018). PubMed: 29662452
  • Hong HN  et al. Cancer-associated fibroblasts promote gastric tumorigenesis through EphA2 activation in a ligand-independent manner. J Cancer Res Clin Oncol 144:1649-1663 (2018). PubMed: 29948146
  • Xiang T  et al. Vasculogenic mimicry formation in EBV-associated epithelial malignancies. Nat Commun 9:5009 (2018). PubMed: 30479336
  • Toma MI  et al. Lack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinoma. PLoS One 9:e102262 (2014). IHC-P ; Human . PubMed: 25025847
  • Park JE  et al. Human Cataract Mutations in EPHA2 SAM Domain Alter Receptor Stability and Function. PLoS One 7:e36564 (2012). ICC/IF . PubMed: 22570727
  • Guo T  et al. Multidimensional Identification of Tissue Biomarkers of Gastric Cancer. J Proteome Res 11:3405-3413 (2012). IHC-P ; Human . PubMed: 22533479

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
For licensing inquiries, please contact partnerships@abcam.com

Sign up